B:
Recently, a significantly longer actuarial survival was found after curative resection (75% 5-year survival) as compared to unresected (40% 5-year survival) patients in a non-randomized study comprising carcinoids and islet cell tumors and where the two groups did not differ in age, pathology, primary tumor site, serum alkaline phosphatase, or percentage of the liver involved (grade C). In another study 5-year survival after potentially curative liver resection was 60% whereas 5-year survival following palliative resection was calculated to be almost 40% (Grade C)